BioXcel Therapeutics Inc
F:BX2
BioXcel Therapeutics Inc
F:BX2
Price:
2.56
EUR
Market Closed
Market Cap:
€96.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioXcel Therapeutics Inc
F:BX2
|
US |
|
Cassius Mining Ltd
ASX:CMD
|
AU |
|
F
|
FirstEnergy Corp
F:FE7
|
US |
|
B
|
Banpu Power PCL
SET:BPP
|
TH |
|
C
|
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
|
CN |
|
S
|
Shree Hanuman Sugar & Industries Ltd
BSE:537709
|
IN |
|
S
|
Savimex Corp
VN:SAV
|
VN |
|
L
|
Lowe's Companies Inc
DUS:LWE
|
US |
|
B
|
Bitcoin Group SE
SWB:ADE
|
DE |
|
B
|
Blackstone Mortgage Trust Inc
F:079A
|
US |
|
D
|
Definitive Healthcare Corp
NASDAQ:DH
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BX2's stock price target?
Not Available
BX2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for BioXcel Therapeutics Inc?
Projected CAGR
147%
147%
The compound annual growth rate for Revenue over the next 8 years is 147%.
What is the Gross Profit forecast for BioXcel Therapeutics Inc?
Projected CAGR
153%
153%
The compound annual growth rate for Gross Profit over the next 8 years is 153%.
